Literature DB >> 19727581

Efficacy of medical therapy in a case of idiopathic pulmonary fibrosis due to gastroesophageal reflux disease.

Franca Dipaola, Andrea Galli, Carlo Selmi, Raffaello Furlan.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19727581     DOI： 10.1007/s11739-009-0301-0

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  5 in total

Review 1.  American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

2.  High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis.

Authors:  G Raghu; T D Freudenberger; S Yang; J R Curtis; C Spada; J Hayes; J K Sillery; C E Pope; C A Pellegrini
Journal:  Eur Respir J       Date:  2006-01       Impact factor: 16.671

Review 3.  Gastroesophageal reflux disease and idiopathic pulmonary fibrosis.

Authors:  Yevgenia Y Pashinsky; Barry W Jaffin; Virginia R Litle
Journal:  Mt Sinai J Med       Date:  2009-02

4.  Sole treatment of acid gastroesophageal reflux in idiopathic pulmonary fibrosis: a case series.

Authors:  Ganesh Raghu; Steve T-Y Yang; Carolyn Spada; Jennifer Hayes; Carlos A Pellegrini
Journal:  Chest       Date:  2006-03       Impact factor: 9.410

5.  Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis.

Authors:  R W Tobin; C E Pope; C A Pellegrini; M J Emond; J Sillery; G Raghu
Journal:  Am J Respir Crit Care Med       Date:  1998-12       Impact factor: 21.405
  5 in total
  2 in total

1.  Epidemiology of idiopathic pulmonary fibrosis: a population-based study in primary care.

Authors:  Sergio Harari; Michele Davì; Alice Biffi; Antonella Caminati; Alessandra Ghirardini; Valeria Lovato; Claudio Cricelli; Francesco Lapi
Journal:  Intern Emerg Med       Date:  2019-09-20       Impact factor: 3.397

2.  Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials.

Authors:  Joyce S Lee; Harold R Collard; Kevin J Anstrom; Fernando J Martinez; Imre Noth; Rhonda S Roberts; Eric Yow; Ganesh Raghu
Journal:  Lancet Respir Med       Date:  2013-06-14       Impact factor: 30.700
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.